Synthesis of 6-(N-alkyl-N-arylamino)pyrimidines as potential antimetabolites.
D000818:Animals; D000963:Antimetabolites / Q000138:chemical synthesis*; D002460:Cell Line; D046508:Culture Techniques; D008956:Models, Chemical; D011743:Pyrimidines / Q000138:chemical synthesis; D012256:Riboflavin; D012510:Sarcoma 180 / Q000188:drug therapy
D000963:Antimetabolites; D011743:Pyrimidines; D012256:Riboflavin